CLINICAL_TRIALS
trial_result
· 2026-04-13
Clinical Trial Update: Angiotensin II for Distributive Shock [Phase 4]
Summary
Phase 4 trial of Angiotensin II (Giapreza) for distributive shock was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Distributive Shock | Phase 4 | Status: TERMINATED | Results posted: 2026-04-13